MINOLI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 1.821
EU - Europa 1.314
AS - Asia 903
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 4.043
Nazione #
US - Stati Uniti d'America 1.812
CN - Cina 893
IE - Irlanda 375
UA - Ucraina 298
FI - Finlandia 177
DE - Germania 167
IT - Italia 91
GB - Regno Unito 78
SE - Svezia 76
FR - Francia 37
BE - Belgio 9
IN - India 8
CA - Canada 7
ES - Italia 2
GT - Guatemala 2
MU - Mauritius 2
RU - Federazione Russa 2
AU - Australia 1
CL - Cile 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
PT - Portogallo 1
Totale 4.043
Città #
Chandler 464
Dublin 375
Jacksonville 370
Nanjing 257
Nanchang 120
Ashburn 104
Princeton 84
Hebei 82
Wilmington 82
Lawrence 81
Shenyang 81
Changsha 76
Beijing 75
Ann Arbor 67
Jiaxing 59
Tianjin 55
Medford 54
Boardman 42
Hangzhou 41
Milan 28
Helsinki 27
Verona 25
Woodbridge 21
Shanghai 13
Des Moines 11
New York 10
Pavia 10
Brussels 9
Kunming 9
Auburn Hills 8
Norwalk 8
Fairfield 7
Seattle 7
Toronto 7
Los Angeles 6
Pune 6
Houston 5
Jinan 5
Guangzhou 4
Berlin 3
Besana in Brianza 3
Ningbo 3
Norwich 3
Taizhou 3
El Salvador 2
Monmouth Junction 2
Mountain View 2
Orange 2
Pittsburgh 2
Rockville 2
Romainville 2
Rome 2
San Francisco 2
Scuola 2
Tappahannock 2
Tradate 2
Washington 2
Zhengzhou 2
Andover 1
Brescia 1
Dearborn 1
Eindhoven 1
Florence 1
Gussago 1
Las Vegas 1
Lisbon 1
London 1
Mcallen 1
Nürnberg 1
Phoenix 1
Pompei 1
Pontevedra 1
Reading 1
Rozzano 1
Sacramento 1
San Giuliano Milanese 1
Serra 1
Shaoxing 1
Southend 1
Tokyo 1
Triuggio 1
Vigevano 1
Totale 2.862
Nome #
Postinfectious neurologic syndromes: A prospective cohort study 84
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 82
A new chromosome instability disorder 82
Listeriosi 76
Acute disseminated encephalomyelitis 72
Sepsi e shock settico 71
Candida infective endocarditis: report of 15 cases from a prospective multicenter study 71
Carbonchio 68
Severe recurrent myelitis in patients with hepatitis C virus infection 68
Detection of HTLV-III specific IgG in the CSF from patient with AIDS and encephalitis. 67
Long-term CD4+ T- cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 66
A 10-years survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian report 65
Prevalence and outcome of hepatitis B virus (HBV) infection following thoracic organ transplantation 61
Infezioni da Brucella 61
Acute transient inflammatory leukoencephalopathy in HIV. 61
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 60
Osteomieliti e artriti infettive 60
Early and late effects of highly active antiretroviral therapy: a 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients 59
Recruitment criteria for acute disseminated encephalomyelitis studies: the need for consensus 59
Xenotropic and polytropic murine leukemia virus-related sequences are not detected in the majority of patients with chronic fatigue syndrome. 59
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1 positive patients after commencement of a new highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER COHORT 58
Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3 58
Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: a multicenter study. 58
Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV-positive patients. 58
Malatttie da Rickettsie 57
Severe recurrent myelitis in patients with hepatitis C virus infection patients 57
Headache attributed to infection: observations on the IHS classification (ICHD-II) 56
Severe steroid-resistant post-infectious encephalomyelitis: general features and effects ofIVIg. 56
Predictors of AIDS-defining events among advanced naive patients after HAART 56
Morphological, cytochemical and ultrastructural studies of a case of systemic mastocytosis. 56
Infezioni da Legionella 55
Varicella zoster virus meningo-encephalo-myelitis in an immunocompetent patient 55
Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors 55
Febbri ricorrenti 54
First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection 54
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection 54
HIV-RELATED ACUTE INFLAMMATORY LEUKOENCEPHALOPATHY OF UNDETERMINED ORIGIN: SYSTEMATIC REVIEW OF THE LITERATURE 53
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 53
Exploratory analysis for the evaluation of lopinavir/ritonavir versus efavirenz- based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER COHORT 51
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 51
Visceral leishmaniasis, systemic lupus erythematosus and acute hepatitis 50
Replication capacity in relation to immunological and virological outcomes in HIV-1 infected treatment-naive subjects 50
Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study 49
Immune reconstitution and control of HIV 49
Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linted immunospot assay. 49
Infectious complications in patients with the novacor left ventricular assist system 48
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal 48
Staphylococcus aureus toxic shock syndrome toxin-1 endocarditis with muscular metastatic abscesses 48
Comparison of four-drug regimens and pairs of sequential three drug regimens as initial therapy for HIV-1 infection 48
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort 47
Circadian secretory pattern of growth hormone, insulin-like growth type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection 47
Post infectious inflammatory disorders: subgroup based on prospective follow-up 47
Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease 47
The effect of HIV-1 resistance mutatioins after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens 46
Leptospirosi 44
Post-exposure rate of tuberculosis infection among health care workers measured with tuberculin skin test convension after unprotected exposure to patients with pulmonary tuberculosis: 6 -years experience in an Italian teaching hospital 43
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 42
Recruitment criteria for acute disseminated encephalomyelitis studies: the need for consensus. 42
Performance of liver stiffness measurements by transient elastography in chronic hepatitis. 42
Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study 42
ItalianPostinfectious Demyelinating Diseases (IPoDD) Study Group; Italian Study Group ofNeuroinfectious Diseases. Recruitment criteria for acute disseminatedencephalomyelitis studies: the need for consensus 41
Evaluation of cytomegalovirus DNAemia versus pp65-antigenemia cut off for guiding preemptive therapy in transplant recipients: a randomized study 41
Riverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART study 40
Vademecum di Malattie Infettive 39
In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis; high in vitro synergistic effect of the association ceftriaxone-fosfomycin. 39
Epidemiology of Mycobacterium tuberculosis infecion in Pavia province, Lombarady, Northern Italy, 1998-2013 39
Aetiology and outcome of penumoniae in HIV-positive patients in the antiretroviral era 39
The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens 38
Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: Case report and review of the literature 38
Predictors of clinical progression among HIV-1 positive patients starting HAART with CD4+ T-cell counts > or= 200 cells/mm3 37
Tuberculosis-induced haemophagocytic syndrome in a patient on haemodialysis treated with anti-thymocyte globulin. 36
Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz 35
Neuropsychological evaluation and follow up in jcv- and non-jcv-related leukoencephalopathies in HIVinfection 34
Surveillance of Toxoplasma gondii infection in recipients of thoracic solid organ transplants 33
Profilassi e terapia delle infezioni micotiche nel trapianto d'organo solido. 29
Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients. 27
Hepatitis C virus (HCV) core serotypes in chronic HCV infection 27
Performance of liver stiffness measurements by transient elastography in chronic hepatitis. 27
Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients. 21
Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized-double-blind SENSE trial 21
Infective endocarditis in patients with hepatic diseases 20
Totale 4.086
Categoria #
all - tutte 12.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 0 7
2019/20201.098 321 436 2 55 6 60 11 59 3 112 30 3
2020/2021509 61 50 13 60 3 68 1 83 12 76 70 12
2021/2022308 2 7 10 7 3 6 4 20 19 2 54 174
2022/20231.237 143 86 17 126 120 144 0 69 487 0 28 17
2023/2024280 39 62 9 24 19 87 1 29 6 4 0 0
Totale 4.086